HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypophyseal non-Hodgkin's lymphoma presenting with clinical panhypopituitarism successfully treated with chemotherapy.

Abstract
A patient is described with a testicular Non-Hodgkin's Lymphoma (NHL) presenting with panhypopituitarism caused by a hypophyseal localization. A 67Gallium scintigraphy showed avid uptake in the hypophyseal region. Obviously 67Gallium could reach the tumor, by the intravenous route, which was the reason to treat the patient with intravenous chemotherapy. A complete remission was induced, which seems to be lasting (+25 months). As far as we know this is the first report of panhypopituitarism caused by a hypophyseal NHL in the hypophysis and successfully treated by intravenous chemotherapy.
AuthorsA R Jonkhoff, P C Huijgens, W O Schreuder, G J Teule, J J Heimans
JournalJournal of neuro-oncology (J Neurooncol) Vol. 17 Issue 2 Pg. 155-8 (Aug 1993) ISSN: 0167-594X [Print] United States
PMID8145058 (Publication Type: Case Reports, Journal Article)
Topics
  • Aged
  • Humans
  • Hypopituitarism (etiology)
  • Lymphoma, Non-Hodgkin (complications, diagnosis, diagnostic imaging, drug therapy)
  • Male
  • Pituitary Neoplasms (complications, diagnosis, diagnostic imaging, drug therapy)
  • Radionuclide Imaging

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: